A trehalose-based tetanus and diphtheria vaccine has passed a first human trial in 60 healthy adults, showing a safety profile and immune response comparable to approved vaccines. Larger trials and regulatory review are still needed, but the technology could reduce reliance on refrigeration in remote clinics.

Thermostable tetanus and diphtheria vaccine clears trial
SOUTHAMPTON UNIVERSITY